2023-03-10
Taimed is exhibiting at the 2023 Bio-Europe Spring 2023-02-03
WEP CLINICAL HAS PARTNERED WITH TAIMED BIOLOGICS TO LAUNCH A TROGARZO NAMED PATIENT PROGRAM 2022-12-08
TaiMed and WEP Clinical officially signed the service contract for the Post-Approval Named Patient Program (PA-NPP)

2022-02-15
QIC Healthcare Forum 2021-10-22
MasterLink Securities October Corparate Day 2021-08-13
2021 Q2 conference

2016-10-30
Ibalizumab study 301 presenation at IDWeek 2016 2015-11-23
TaiMed Biologics IPO 2015-11-23
Presentation for IPO

2013-10-01
"Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity", Nature Biotechnology